TY - JOUR
T1 - Advancing Mental heaLth Provision In PHarmacY (AMPLIPHY)
T2 - A feasibility study
AU - Gorton, Hayley C.
AU - Riste, Lisa
AU - Littlewood, Donna
AU - Pickering, Gary
AU - Armitage, Christopher J.
AU - Ashcroft, Darren M.
N1 - Funding Information:
This work was funded by the National Institute for Health Research (NIHR) Greater Manchester Patient Safety Translational Research Centre . The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. The project was a collaboration with Lloyds Pharmacy UK. Armitage is supported by the NIHR Greater Manchester Biomedical Research Centre .
Publisher Copyright:
© 2021 The Authors
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2022/8/1
Y1 - 2022/8/1
N2 - Background Specifically-designed community pharmacy-based services represent opportunities to support people with their mental health. As few such services exist worldwide, the Advancing Mental HeaLth Provision In PharmacY (AMPLIPHY) was designed with stakeholders. The purpose was to support people with their mental health when initiated on new prescription or change in drug, dose or quantity of antidepressant, through a series of consultations (up to 3 months). Objective(s) The aim was to evaluate the feasibility of the AMPLIPHY service. The objectives were to: i) pilot the service; ii) examine anonymous consultation data to understand patients' characteristics, priorities and consultation focus and iii) Evaluate pharmacists’ experiences. Methods This service evaluation involved a concurrent mixed methods design. Patient characteristics were extracted from consultation notes and descriptive statistics applied. Content analysis was used to summarise consultation foci and comparisons between patients’ priorities with consultation content were made. Pharmacists were interviewed at the start (n = 10) and end (n = 4) of the pilot with themes identified using thematic analysis. Results Seventy-six patients participated (63% of recruitment target). The median age was 39 (IQR 28–47) and 62% were female. Seventy percent of patients had one consultation, 26% had two and 4% had three. Prescription for new antidepressant was the most common reason for entry (74%) and sertraline was most prescribed (46%). Consultations commonly focussed on life experience (n = 51), medication (n = 47), health (n = 42), support (n = 36) and patients' expression of their feelings (n = 31). The pharmacists’ experiences were summarised in three themes: i) Motivation, ii) Practicalities and iii) Experience and Outcomes. Conclusions Pharmacists were motivated to deliver this novel service and some patients were willing to join the service. Analysis of patient demographics, consultation notes and interviews provide insight into the strengths and challenges of the service and provides a blueprint for future service developments.
AB - Background Specifically-designed community pharmacy-based services represent opportunities to support people with their mental health. As few such services exist worldwide, the Advancing Mental HeaLth Provision In PharmacY (AMPLIPHY) was designed with stakeholders. The purpose was to support people with their mental health when initiated on new prescription or change in drug, dose or quantity of antidepressant, through a series of consultations (up to 3 months). Objective(s) The aim was to evaluate the feasibility of the AMPLIPHY service. The objectives were to: i) pilot the service; ii) examine anonymous consultation data to understand patients' characteristics, priorities and consultation focus and iii) Evaluate pharmacists’ experiences. Methods This service evaluation involved a concurrent mixed methods design. Patient characteristics were extracted from consultation notes and descriptive statistics applied. Content analysis was used to summarise consultation foci and comparisons between patients’ priorities with consultation content were made. Pharmacists were interviewed at the start (n = 10) and end (n = 4) of the pilot with themes identified using thematic analysis. Results Seventy-six patients participated (63% of recruitment target). The median age was 39 (IQR 28–47) and 62% were female. Seventy percent of patients had one consultation, 26% had two and 4% had three. Prescription for new antidepressant was the most common reason for entry (74%) and sertraline was most prescribed (46%). Consultations commonly focussed on life experience (n = 51), medication (n = 47), health (n = 42), support (n = 36) and patients' expression of their feelings (n = 31). The pharmacists’ experiences were summarised in three themes: i) Motivation, ii) Practicalities and iii) Experience and Outcomes. Conclusions Pharmacists were motivated to deliver this novel service and some patients were willing to join the service. Analysis of patient demographics, consultation notes and interviews provide insight into the strengths and challenges of the service and provides a blueprint for future service developments.
KW - Mental health
KW - Antidepressant
KW - Pharmaceutical services
KW - Community pharmacy services
UR - http://www.scopus.com/inward/record.url?scp=85119018422&partnerID=8YFLogxK
U2 - 10.1016/j.sapharm.2021.11.001
DO - 10.1016/j.sapharm.2021.11.001
M3 - Article
VL - 18
SP - 3414
EP - 3424
JO - Research in Social and Administrative Pharmacy
JF - Research in Social and Administrative Pharmacy
SN - 1551-7411
IS - 8
ER -